نتایج جستجو برای: mut t2

تعداد نتایج: 31546  

Journal: :Pediatrics 2012
Colin J O'Shea Jennifer L Sloan Edythe A Wiggs Maryland Pao Andrea Gropman Eva H Baker Irini Manoli Charles P Venditti Joseph Snow

OBJECTIVE Methylmalonic acidemia (MMA) is a metabolic disorder with a poorly defined long-term neurocognitive phenotype. We studied the neuropsychological outcomes of patients and examined clinical covariates that influenced cognition. METHODS A diverse cohort with mut, cblA, or cblB subtypes of isolated MMA (N = 43), ages 2 to 32 years, were evaluated at a single center over a 6-year period....

Journal: :Molecular Therapy 2010
Randy J Chandler Charles P Venditti

Methylmalonic acidemia (MMA) is an organic acidemia caused by deficient activity of the mitochondrial enzyme methylmalonyl-CoA mutase (MUT). This disorder is associated with lethal metabolic instability and carries a poor prognosis for long-term survival. A murine model of MMA that replicates a severe clinical phenotype was used to examine the efficacy of recombinant adeno-associated virus (rAA...

2012
Frans van Hoorn Maria E. Campian Anje Spijkerboer Marieke T. Blom R. Nils Planken Albert C. van Rossum Jacques M T. de Bakker Arthur A M. Wilde Maarten Groenink Hanno L. Tan

BACKGROUND The cardiac sodium channel (Na(v)1.5) controls cardiac excitability. Accordingly, SCN5A mutations that result in loss-of-function of Na(v)1.5 are associated with various inherited arrhythmia syndromes that revolve around reduced cardiac excitability, most notably Brugada syndrome (BrS). Experimental studies have indicated that Na(v)1.5 interacts with the cytoskeleton and may also be ...

Journal: :Blood 2011
Emi Goto Akihiro Tomita Fumihiko Hayakawa Akihide Atsumi Hitoshi Kiyoi Tomoki Naoe

Arsenic trioxide (As₂O₃) is a highly effective treatment for patients with refractory/relapsed acute promyelocytic leukemia (APL), but resistance to As₂O₃ has recently been seen. In the present study, we report the findings that 2 of 15 patients with refractory/relapsed APL treated with As₂O₃ were clinically As₂O₃ resistant. Leukemia cells from these 2 patients harbored missense mutations in pr...

Journal: :The Journal of clinical investigation 2017
Gary Kohanbash Diego A Carrera Shruti Shrivastav Brian J Ahn Naznin Jahan Tali Mazor Zinal S Chheda Kira M Downey Payal B Watchmaker Casey Beppler Rolf Warta Nduka A Amankulor Christel Herold-Mende Joseph F Costello Hideho Okada

Mutations in the isocitrate dehydrogenase genes IDH1 and IDH2 are among the first genetic alterations observed during the development of lower-grade glioma (LGG). LGG-associated IDH mutations confer gain-of-function activity by converting α-ketoglutarate to the oncometabolite R-2-hydroxyglutarate (2HG). Clinical samples and gene expression data from The Cancer Genome Atlas (TCGA) demonstrate re...

2013
Carrie Luu Eileen L. Heinrich Marjun Duldulao Amanda K. Arrington Marwan Fakih Julio Garcia-Aguilar Joseph Kim

Recent reports have indicated that KRAS and TP53 mutations predict response to therapy in colorectal cancer. However, little is known about the relationship between these two common genetic alterations. Micro-RNAs (miRNAs), a class of noncoding RNA implicated in cellular processes, have been increasingly linked to KRAS and TP53. We hypothesized that lethal-7a (let-7a) miRNA regulates KRAS throu...

2015
James E. Korkola Eric A. Collisson Laura M. Heiser Chris Oates Nora Bayani Sleiman Itani Amanda Esch Wallace Thompson Obi L. Griffith Nicholas J. Wang Wen-Lin Kuo Brian Cooper Jessica Billig Safiyyah Ziyad Jenny L. Hung Lakshmi Jakkula Heidi Feiler Yiling Lu Gordon B. Mills Paul T. Spellman Claire Tomlin Sach Mukherjee Joe W. Gray

We report here on experimental and theoretical efforts to determine how best to combine drugs that inhibit HER2 and AKT in HER2(+) breast cancers. We accomplished this by measuring cellular and molecular responses to lapatinib and the AKT inhibitors (AKTi) GSK690693 and GSK2141795 in a panel of 22 HER2(+) breast cancer cell lines carrying wild type or mutant PIK3CA. We observed that combination...

Journal: :Blood 2009
Verena Ingeborg Gaidzik Richard Friedrich Schlenk Simone Moschny Annegret Becker Lars Bullinger Andrea Corbacioglu Jürgen Krauter Brigitte Schlegelberger Arnold Ganser Hartmut Döhner Konstanze Döhner

To evaluate the incidence and clinical impact of WT1 gene mutations in younger adult patients with cytogenetically normal acute myeloid leukemia (CN-AML), sequencing of the complete coding region was performed in diagnostic samples from 617 patients who were treated on 3 German-Austrian AML Study Group protocols. WT1 mutations were identified in 78 (12.6%) of the 617 patients; mutations cluster...

Journal: :Cancer research 2013
Tarah M Regan Anderson Danielle L Peacock Andrea R Daniel Gregory K Hubbard Kristopher A Lofgren Brian J Girard Alexandra Schörg David Hoogewijs Roland H Wenger Tiffany N Seagroves Carol A Lange

Basal-type triple-negative breast cancers (TNBC) are aggressive and difficult to treat relative to luminal-type breast cancers. TNBC often express abundant Met receptors and are enriched for transcriptional targets regulated by hypoxia-inducible factor-1α (HIF-1α), which independently predict cancer relapse and increased risk of metastasis. Brk/PTK6 is a critical downstream effector of Met sign...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2016
Salvatore Iovino Alison M Burkart Laura Warren Mary Elizabeth Patti C Ronald Kahn

Induced pluripotent stem cells (iPS cells) represent a unique tool for the study of the pathophysiology of human disease, because these cells can be differentiated into multiple cell types in vitro and used to generate patient- and tissue-specific disease models. Given the critical role for skeletal muscle insulin resistance in whole-body glucose metabolism and type 2 diabetes, we have created ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید